Skip to content

Effect of intravenous combined use of dexamethasone and dexmedetomidine on rebound pain after brachial plexus block and chronic postoperative pain

Effect of intravenous combined use of dexamethasone and dexmedetomidine on rebound pain after brachial plexus block and chronic postoperative pain

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600125679
Enrollment
Unknown
Registered
2026-05-29
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative pain

Interventions

Control group (Group C):Intravenous infusion of normal saline (syringe 1 and syringe 2 both contain normal saline)
Dexamethasone group (Group D):Intravenous infusion of dexamethasone 8 mg (syringe 1) + normal saline (syringe 2)
Dexamethasone combined with dexmedetomidine group (Group DD):Intravenous infusion of dexamethasone 8 mg (syringe 1) + dexmedetomidine 1 µg/kg (syringe 2)

Sponsors

The People's Hospital of Tongnan District, Chongqing
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Age = 18 years; 2. Body mass index (BMI) < 30 kg/m²; 3. American Society of Anesthesiologists (ASA) physical status I–III; 4. Willing to participate in this study and sign the informed consent form;5. Electively perform upper limb fracture surgery under brachial plexus block.

Exclusion criteria

Exclusion criteria: 1. Patient refusal to participate; 2. Presence of neuropathy or sensory abnormality in the surgical limb; 3. Allergy or contraindication to any of the study drugs (ropivacaine, dexamethasone, dexmedetomidine); 4. Severe cardiac, pulmonary, hepatic, or renal disease; 5. Uncontrolled diabetes mellitus; 6. Coagulation dysfunction; 7. Systemic infection or local infection at the puncture site; 8. Pregnancy or breastfeeding; 9. History of alcohol/substance abuse; 10. History of chronic pain requiring regular opioid use within 1 month before surgery; 11. Inability to cooperate with follow-up or complete questionnaires.

Design outcomes

Primary

MeasureTime frame
The incidence of rebound pain ;

Secondary

MeasureTime frame
intensity of rebound pain;Onset time of rebound pain;NRS scores at rest and during movement within 48 hours postoperatively;Postoperative opioid consumption;Postoperative sleep assessment;Patient satisfaction;Incidence of chronic postoperative pain at 3 and 6 months;Adverse events (bradycardia, nausea and vomiting, etc.);

Countries

China

Contacts

Public ContactXiaofeng Zhou

The People's Hospital of Tongnan District, Chongqing

819629376@qq.com+86 136 1827 5565

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026